United Biomedical Inc. (UBI) Revenue and Competitors
Estimated Revenue & Valuation
- United Biomedical Inc. (UBI)'s estimated annual revenue is currently $8.5M per year.
- United Biomedical Inc. (UBI)'s estimated revenue per employee is $155,000
Employee Data
- United Biomedical Inc. (UBI) has 55 Employees.
- United Biomedical Inc. (UBI) grew their employee count by 2% last year.
United Biomedical Inc. (UBI)'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP | Reveal Email/Phone |
2 | Head and Hands Bioanalysis and Peptide Chemistry | Reveal Email/Phone |
3 | VP Operation/Biological Product Development | Reveal Email/Phone |
4 | VP | Reveal Email/Phone |
5 | Director, Business Administration | Reveal Email/Phone |
6 | Regulatory Affairs Associate | Reveal Email/Phone |
7 | Supervisor | Reveal Email/Phone |
8 | Research Associate | Reveal Email/Phone |
9 | President | Reveal Email/Phone |
10 | United Biomedical | Reveal Email/Phone |
United Biomedical Inc. (UBI) Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is United Biomedical Inc. (UBI)?
United Biomedical, Inc (UBI) is a privately held multinational biopharmaceutical company dedicated to the discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. Our product pipeline is filled with our new line of synthetic peptide-based biologicals for the treatment and prevention of Alzheimer’s Disease, AIDS, and Allergy, along with a portfolio of animal health diseases. These products are based on our proprietary designer peptides, vaccine formulation systems, and methods to manufacture therapeutic monoclonal antibodies. Our platform technologies are also being used to develop a line of biosimilar versions of widely used protein and antibody drugs whose patents are about to expire. UBI’s proprietary designer peptide technology has been used to produce a line of blood screening diagnostics and the first successfully commercialized synthetic peptide vaccine. Additional revenue streams are generated from pharmaceutical contract manufacturing by our subsidiary UBI-Asia and various sponsorships in product development.
keywords:N/A
N/A
Total Funding
55
Number of Employees
$8.5M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Hauppauge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $35M | 56 | 2% | N/A |
#2 | $11.3M | 56 | -2% | N/A |
#3 | $7.2M | 57 | N/A | N/A |
#4 | $20.9M | 58 | 7% | N/A |
#5 | $3.5M | 59 | -5% | N/A |